1681 — Consun Pharmaceutical Balance Sheet
0.000.00%
- HK$8.05bn
- HK$4.53bn
- CNY2.97bn
- 99
- 76
- 94
- 99
Annual balance sheet for Consun Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,940 | 2,426 | 3,039 | 3,583 | 3,866 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 458 | 370 | 296 | 310 | 370 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,659 | 3,056 | 3,623 | 4,278 | 4,551 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 676 | 725 | 746 | 739 | 798 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,950 | 4,363 | 4,892 | 5,508 | 5,853 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,332 | 1,357 | 1,350 | 1,495 | 1,371 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,730 | 1,745 | 1,747 | 1,881 | 1,755 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 2,220 | 2,618 | 3,145 | 3,627 | 4,098 |
Total Liabilities & Shareholders' Equity | 3,950 | 4,363 | 4,892 | 5,508 | 5,853 |
Total Common Shares Outstanding |